Drug intelligence / Profile preview

pinazepam

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Pinazepam is a benzodiazepine derivative used primarily for the treatment of anxiety and, in some cases, severe insomnia. It acts as an anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant. Mechanistically, pinazepam enhances the inhibitory effects of gamma-aminobutyric acid (GABA) at the GABA-A receptor by binding to a specific site on the receptor complex. This increases chloride influx into neurons, reducing neuronal excitability and producing calming effects on the central nervous system[2][3][5]. Unlike many other benzodiazepines, pinazepam is noted for its limited hypnotic and motor impairment properties at therapeutic doses; it is considered more suitable for daytime use due to minimal impact on intellectual or psychomotor function[3]. After oral administration it is rapidly absorbed and metabolized mainly to N-desmethyldiazepam (nordazepam) and oxazepam[3]. Pinazepam has a longer elimination half-life in elderly patients. Pinazepam is classified as a Schedule IV controlled substance in several jurisdictions due to its potential for dependence with prolonged use[1][6]. Its unique propargyl group at the N1 position distinguishes it structurally from other benzodiazepines[3][7].

Brand names
DomarDuna
Other names
pinazepamPinazepam [INN]52463-83-9
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on pinazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pinazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call